Abstract
Over a 2-year period, a predeposit autologous blood transfusion service was provided for all patients undergoing elective surgery for left-sided colonic or rectal cancer in one hospital. Of 129 such patients, 28 were suitable for autologous donation. Eight of these received autologous blood only, 13 required no transfusion, and seven needed additional homologous blood. Thus, although predeposit autologous transfusion for patients with colorectal cancer is possible, only a very small proportion are likely to derive any benefit which it might confer.
| Original language | English |
|---|---|
| Pages (from-to) | 355-357 |
| Number of pages | 3 |
| Journal | British Journal of Surgery |
| Volume | 79 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Apr 1992 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Aged
- Blood Transfusion, Autologous
- Colonic Neoplasms
- Feasibility Studies
- Female
- Humans
- Male
- Prognosis
- Rectal Neoplasms
Fingerprint
Dive into the research topics of 'Predeposit autologous blood transfusion in patients with colorectal cancer: a feasibility study'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver